应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01877 君实生物
交易中 01-05 15:44:04
22.760
+0.480
+2.15%
最高
23.300
最低
21.400
成交量
402.20万
今开
21.960
昨收
22.280
日振幅
8.53%
总市值
233.75亿
流通市值
59.18亿
总股本
10.27亿
成交额
9,114万
换手率
1.55%
流通股本
2.60亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
中国创新药大爆发,一年出海狂揽9400亿,超越美国
21世纪经济报道 · 01-04 20:41
中国创新药大爆发,一年出海狂揽9400亿,超越美国
JAMA Oncol:特瑞普利单抗 vs达卡巴嗪?中国晚期肢端型黑色素瘤一线治疗的疗效与安全性评估
动脉网 · 01-04 13:25
JAMA Oncol:特瑞普利单抗 vs达卡巴嗪?中国晚期肢端型黑色素瘤一线治疗的疗效与安全性评估
每日卖空追踪 | 君实生物 01月02日卖空量成交1.52万股,卖空比例为1.68%
市场透视 · 01-02 16:30
每日卖空追踪 | 君实生物 01月02日卖空量成交1.52万股,卖空比例为1.68%
每周股票复盘:君实生物(688180)募投项目延期至2028年
证券之星 · 01-02
每周股票复盘:君实生物(688180)募投项目延期至2028年
君实生物获准注册200亿元科技创新票据
金吾财讯 · 2025-12-28
君实生物获准注册200亿元科技创新票据
君实生物新增一起对外投资,被投资公司为宁波甬元兴仑君金创业投资合伙企业(有限合伙)
证券之星APP · 2025-12-28
君实生物新增一起对外投资,被投资公司为宁波甬元兴仑君金创业投资合伙企业(有限合伙)
每周股票复盘:君实生物(688180)获准注册20亿元中期票据
证券之星 · 2025-12-28
每周股票复盘:君实生物(688180)获准注册20亿元中期票据
京东健康与君实生物达成战略合作 独家首发新一代口腔黏膜敷料“速舒®”
宿迁网 · 2025-12-27
京东健康与君实生物达成战略合作 独家首发新一代口腔黏膜敷料“速舒®”
临港集团加速培育生物医药:以“基金+基地”模式撬动1700亿元基金规模
澎湃新闻 · 2025-12-27
临港集团加速培育生物医药:以“基金+基地”模式撬动1700亿元基金规模
君实生物12月25日获融资买入1621.48万元,融资余额13.76亿元
新浪财经 · 2025-12-26
君实生物12月25日获融资买入1621.48万元,融资余额13.76亿元
君实生物:20亿元中期票据获批注册
财中社 · 2025-12-25
君实生物:20亿元中期票据获批注册
国内商保发展和集采优化 创新药产业链持续活跃
金证研 · 2025-12-24
国内商保发展和集采优化 创新药产业链持续活跃
每日卖空追踪 | 君实生物 12月24日卖空量成交13.38万股,卖空比例为9.63%
市场透视 · 2025-12-24
每日卖空追踪 | 君实生物 12月24日卖空量成交13.38万股,卖空比例为9.63%
君实生物12月24日遭主力抛售411.2万元
市场透视 · 2025-12-24
君实生物12月24日遭主力抛售411.2万元
每日卖空追踪 | 君实生物 12月22日卖空量成交5.06万股,卖空比例为2.72%
市场透视 · 2025-12-22
每日卖空追踪 | 君实生物 12月22日卖空量成交5.06万股,卖空比例为2.72%
君实生物12月22日主力净流出367.4万元 散户资金买入
市场透视 · 2025-12-22
君实生物12月22日主力净流出367.4万元 散户资金买入
每日卖空追踪 | 君实生物 12月19日卖空量成交25.24万股,卖空比例为8.58%
市场透视 · 2025-12-19
每日卖空追踪 | 君实生物 12月19日卖空量成交25.24万股,卖空比例为8.58%
医药股集体走高 药明生物(02269)涨5.93% 机构料明年板块稳中向好态势延续
金吾财讯 · 2025-12-19
医药股集体走高 药明生物(02269)涨5.93% 机构料明年板块稳中向好态势延续
君实生物:上海檀英拟减持不超2%股份
每日经济新闻 · 2025-12-18
君实生物:上海檀英拟减持不超2%股份
每日卖空追踪 | 君实生物 12月17日卖空量成交2.06万股,卖空比例为0.89%
市场透视 · 2025-12-17
每日卖空追踪 | 君实生物 12月17日卖空量成交2.06万股,卖空比例为0.89%
加载更多
公司概况
公司名称:
君实生物
所属市场:
SEHK
上市日期:
--
主营业务:
上海君实生物医药科技股份有限公司是一家主要从事创新驱动生物制药业务的中国公司。该公司主营业务为创新药物的发现、临床研究和开发。该公司的主要产品包括特立普珠单抗注射液、依替维单抗、阿达木单抗注射液等用于治疗恶性肿瘤、自身免疫系统疾病、慢性代谢疾病、神经系统疾病和感染性疾病的药物。该公司还从事重组人源化抗PCSK9单克隆抗体注射液等药物的临床研发。该公司主要为国内外市场提供产品。
发行价格:
--
{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"君实生物","latestPrice":22.76,"timestamp":1767599044212,"preClose":22.28,"halted":0,"volume":4022000,"delay":0,"floatShares":260000000,"shares":1027000000,"eps":-1.4515606990436436,"marketStatus":"交易中","change":0.48,"latestTime":"01-05 15:44:04","open":21.96,"high":23.3,"low":21.4,"amount":91136575,"amplitude":0.085278,"askPrice":22.82,"askSize":2400,"bidPrice":22.74,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-1.0707582652565342,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1767600600000},"marketStatusCode":2,"adr":0,"listingDate":1545580800000,"exchange":"SEHK","adjPreClose":22.28,"openAndCloseTimeList":[[1767576600000,1767585600000],[1767589200000,1767600000000]],"volumeRatio":1.497943,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"君实生物","latestPrice":36.42,"timestamp":1767596400000,"preClose":34.16,"halted":0,"volume":14543500,"delay":0,"premium":"-44.03"}},"requestUrl":"/m/hq/s/01877","defaultTab":"news","newsList":[{"id":"2601021958","title":"中国创新药大爆发,一年出海狂揽9400亿,超越美国","url":"https://stock-news.laohu8.com/highlight/detail?id=2601021958","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601021958?lang=zh_cn&edition=full","pubTime":"2026-01-04 20:41","pubTimestamp":1767530460,"startTime":"0","endTime":"0","summary":"热潮从已披露的数据可见,2025年,中国创新药对外授权交易总金额超过1300亿美元,授权交易数量超过150笔,远超2024年全年519亿美元和94笔。中国创新药交易额已占全球总额的49%,一举超过美国。其中,新一代IO基石疗法IBI363与武田制药达成共同开发协议,双方将在全球共同开发,并在美国共同商业化。有别于中国创新药出海的传统路径,在这种创新的“合伙人模式”下,中国药企不再是单纯的授权方。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104204611a49af4fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104204611a49af4fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","01877","BK1574","BK1515","BK1583","BK1161"],"gpt_icon":0},{"id":"2600042608","title":"JAMA Oncol:特瑞普利单抗 vs达卡巴嗪?中国晚期肢端型黑色素瘤一线治疗的疗效与安全性评估","url":"https://stock-news.laohu8.com/highlight/detail?id=2600042608","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600042608?lang=zh_cn&edition=full","pubTime":"2026-01-04 13:25","pubTimestamp":1767504300,"startTime":"0","endTime":"0","summary":"JAMA Oncology发表了一项在中国11个中心进行的多中心、开放标签的III期随机临床试验(MELATORCH研究),旨在比较PD-1抑制剂特瑞普利单抗与达卡巴嗪在晚期肢端型黑色素瘤一线治疗中的疗效与安全性。肢端黑色素瘤在中国占所有病例的50%,且预后较差,而西方国家主要以非肢端皮肤黑色素瘤为主。尽管免疫治疗已改变晚期黑色素瘤的治疗格局,但针对未经治疗的肢端黑色素瘤患者,PD-1抑制剂的疗效与安全性缺乏高质量证据支持。在中国,对于无BRAF突变的晚期黑色素瘤,化疗(尤其是达卡巴嗪)一直是唯一的一线标准治疗方案,但其疗效有限。MELATORCH研究为这一临床难题提供了关键答案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104133317a499b6fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104133317a499b6fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1515","BK1161","BK1583"],"gpt_icon":0},{"id":"2600958063","title":"每日卖空追踪 | 君实生物 01月02日卖空量成交1.52万股,卖空比例为1.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600958063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600958063?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:30","pubTimestamp":1767342626,"startTime":"0","endTime":"0","summary":"君实生物北京时间01月02日,涨4.4%,卖空量成交1.52万股,较上一交易日减少66.67%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163305a6eb2a11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163305a6eb2a11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1515","01877"],"gpt_icon":0},{"id":"2600035453","title":"每周股票复盘:君实生物(688180)募投项目延期至2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=2600035453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600035453?lang=zh_cn&edition=full","pubTime":"2026-01-02 01:59","pubTimestamp":1767290347,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,君实生物报收于34.99元,较上周的35.41元下跌1.19%。国泰海通证券股份有限公司关于上海君实生物医药科技股份有限公司募集资金投资项目延期的核查意见君实生物因项目实际进展需要,拟将2022年度向特定对象发行A股股票的募投项目实施期限进行调整。创新药研发项目实施期限由2025年12月延期至2028年12月,上海君实生物科技总部及研发基地项目由2025年12月延期至2026年6月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688180","BK1161","01877","BK0239","BK1583","BK1515"],"gpt_icon":0},{"id":"2594222040","title":"君实生物获准注册200亿元科技创新票据","url":"https://stock-news.laohu8.com/highlight/detail?id=2594222040","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594222040?lang=zh_cn&edition=full","pubTime":"2025-12-28 19:32","pubTimestamp":1766921576,"startTime":"0","endTime":"0","summary":"金吾财讯| 上海君实生物医药科技股份有限公司于2025年12月28日自愿发布公告称,公司近日收到中国银行间市场交易商协会下发的《接受注册通知书》。根据通知书,交易商协会接受公司科技创新票据注册,注册额度为人民币200亿元,注册额度自通知书落款之日起2年内有效,由上海银行股份有限公司主承销。公司可在注册有效期内分期发行科技创新票据,发行前需依据相关规定履行备案程序。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251228195141a6d907fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251228195141a6d907fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","BK1583","01877"],"gpt_icon":0},{"id":"2594222025","title":"君实生物新增一起对外投资,被投资公司为宁波甬元兴仑君金创业投资合伙企业(有限合伙)","url":"https://stock-news.laohu8.com/highlight/detail?id=2594222025","media":"证券之星APP","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594222025?lang=zh_cn&edition=full","pubTime":"2025-12-28 03:55","pubTimestamp":1766865309,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP显示,君实生物新增一起对外投资事件,被投资公司为宁波甬元兴仑君金创业投资合伙企业,法定代表人,投资占比为49%。目前,君实生物共存在对外投资39项,投资占比前20的项目见下表:通过天眼查大数据分析,上海君实生物医药科技股份有限公司共对外投资了42家企业,参与招投标项目43次;财产线索方面有商标信息170条,专利信息119条,著作权信息10条;此外企业还拥有行政许可141个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251228040210a6d6e916&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251228040210a6d6e916&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01877","BK1583","BK1161"],"gpt_icon":0},{"id":"2594244012","title":"每周股票复盘:君实生物(688180)获准注册20亿元中期票据","url":"https://stock-news.laohu8.com/highlight/detail?id=2594244012","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594244012?lang=zh_cn&edition=full","pubTime":"2025-12-28 03:26","pubTimestamp":1766863572,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,君实生物报收于34.99元,较上周的35.41元下跌1.19%。本周,君实生物12月23日盘中最高价报35.49元。本周关注点公司公告汇总:君实生物收到交易商协会通知,科技创新债券注册获受理,注册金额为20亿元。注册品种为中期票据,注册金额为20亿元,注册额度自通知书落款之日起2年内有效,由上海银行股份有限公司主承销。公司将根据授权及监管要求择机实施发行,并履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1583","01877","BK1515","688180","BK0239"],"gpt_icon":0},{"id":"2594524829","title":"京东健康与君实生物达成战略合作 独家首发新一代口腔黏膜敷料“速舒®”","url":"https://stock-news.laohu8.com/highlight/detail?id=2594524829","media":"宿迁网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594524829?lang=zh_cn&edition=full","pubTime":"2025-12-27 15:59","pubTimestamp":1766822374,"startTime":"0","endTime":"0","summary":"近日,京东健康与本土创新生物制药企业君实生物正式达成战略合作,共同推动肿瘤患者口腔黏膜炎护理的生态化服务升级。12月27日,新一代口腔黏膜液体敷料(速舒)在京东健康独家首发,为患者提供精准、规范、便捷的全链路口腔健康解决方案。京东健康始终致力于提升医疗健康服务的精准性与可及性。此次携手君实生物首发速舒口腔黏膜液体敷料,也标志着京东健康在肿瘤护理细分领域的服务能力进一步深化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251227171724a6d59433&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251227171724a6d59433&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0051755006.USD","06618","01877","86618","BK1615","SGXZ86797644.SGD","BK1515","BK1591","BK1571","SGXZ62798434.SGD","BK1142","BK1247","LU0456827905.SGD","BK1583","BK1589","BK1161"],"gpt_icon":0},{"id":"2594212506","title":"临港集团加速培育生物医药:以“基金+基地”模式撬动1700亿元基金规模","url":"https://stock-news.laohu8.com/highlight/detail?id=2594212506","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594212506?lang=zh_cn&edition=full","pubTime":"2025-12-27 11:15","pubTimestamp":1766805354,"startTime":"0","endTime":"0","summary":"目前,该集团正以“一流园区创新生态集成服务商和总运营商”的定位,加速培育生物医药等前沿产业。龚伟表示,立足“十五五”规划关键节点,集团正从“空间提供者”转型“生态构建者”,针对生物医药产业特性,以“基金+基地”模式撬动1700亿元基金规模,构建“接力式”资金加速体系。据介绍,“招投联动”是临港生物医药产业生态赋能的关键引擎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251227111804a6d4be4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251227111804a6d4be4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1515","01877"],"gpt_icon":0},{"id":"2594921335","title":"君实生物12月25日获融资买入1621.48万元,融资余额13.76亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594921335","media":"新浪财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594921335?lang=zh_cn&edition=full","pubTime":"2025-12-26 10:09","pubTimestamp":1766714961,"startTime":"0","endTime":"0","summary":"两融数据显示,当日君实生物获融资买入额1621.48万元,融资偿还2311.87万元,融资净买入-690.39万元。截至12月25日,君实生物融资融券余额合计13.90亿元。融资方面,君实生物当日融资买入1621.48万元。融券方面,君实生物12月25日融券偿还821.00股,融券卖出3100.00股,按当日收盘价计算,卖出金额10.85万元;融券余量39.42万股,融券余额1379.83万元,超过近一年90%分位水平,处于高位。截至9月30日,君实生物股东户数3.59万,较上期增加15.17%;人均流通股21361股,较上期减少12.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226101237a6d0a647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226101237a6d0a647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1583","01877","BK1161"],"gpt_icon":0},{"id":"2594236952","title":"君实生物:20亿元中期票据获批注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2594236952","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594236952?lang=zh_cn&edition=full","pubTime":"2025-12-25 17:38","pubTimestamp":1766655481,"startTime":"0","endTime":"0","summary":"12月25日,君实生物(688180/01877)发布公告,中国银行间市场交易商协会决定接受公司科技创新债券注册。此次注册的基础品种为中期票据,注册金额为20亿元,注册额度自通知书落款之日起2年内有效,主承销商为上海银行(601229)。2025年前三季度,君实生物实现收入18.06亿元,归母净利润-5.96亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512253601959357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1515","688180","01877","BK0239","BK1161"],"gpt_icon":0},{"id":"2593477930","title":"国内商保发展和集采优化 创新药产业链持续活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2593477930","media":"金证研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593477930?lang=zh_cn&edition=full","pubTime":"2025-12-24 21:11","pubTimestamp":1766581900,"startTime":"0","endTime":"0","summary":"随着国内商保发展和集采优化,创新药产业链高景气有望延续。当前支持创新药产业发展已成为政策导向,2025年北京、上海、重庆、四川等多地出台相关政策,推动创新药行业高质量发展。近日,2026年医保药品目录和商保药品目录发布,首次在基本医保目录之外增设商保创新药目录。创新药长期产业趋势确定,在国内政策支持以及美联储进入降息周期的背景下,全球创新药研发持续活跃,2026年还有大量BD落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224211713a6ca8bf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224211713a6ca8bf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417516902.SGD","LU2488822045.USD","BK1574","01877","IE00B5MMRT66.SGD","LU2778985437.USD","LU1961090484.USD","LU0540923850.HKD","BK1161","LU0348825331.USD","LU2399975544.HKD","IE00BPRC5H50.USD","09926","LU0634319403.HKD","LU0348735423.USD","LU0348783233.USD","01276","LU0348784397.USD","LU0417516571.SGD","LU0561508036.HKD","LU0348767384.USD","ONC","LU2476274720.SGD","01801","06978","LU2476274308.USD","LU0348827113.USD","LU1720050803.USD","LU0417516738.SGD","LU0348766576.USD","LU1794554557.SGD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2594288113","title":"每日卖空追踪 | 君实生物 12月24日卖空量成交13.38万股,卖空比例为9.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594288113","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594288113?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:30","pubTimestamp":1766565023,"startTime":"0","endTime":"0","summary":"君实生物北京时间12月24日,跌3.92%,卖空量成交13.38万股,较上一交易日增加152.45%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163334a6c98424&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163334a6c98424&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1583","BK1161","BK1515"],"gpt_icon":0},{"id":"2594288485","title":"君实生物12月24日遭主力抛售411.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594288485","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594288485?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:15","pubTimestamp":1766564141,"startTime":"0","endTime":"0","summary":"12月24日, 君实生物股价跌3.92%,报收22.56元,成交金额3198.0万元,换手率0.53%,振幅5.20%,量比0.60。君实生物今日主力资金净流出411.2万元,连续3日净流出,上一交易日主力净流出150.4万元。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为70.00%,平均跌幅为3.18%。该股近5个交易日下跌1.83%,主力资金累计净流出242.1万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入1919.7万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224161920a6c972bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224161920a6c972bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1515","BK1583","BK1161"],"gpt_icon":0},{"id":"2593487243","title":"每日卖空追踪 | 君实生物 12月22日卖空量成交5.06万股,卖空比例为2.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593487243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593487243?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392226,"startTime":"0","endTime":"0","summary":"君实生物北京时间12月22日,跌0.6%,卖空量成交5.06万股,较上一交易日减少89.47%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163407a6c09afa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163407a6c09afa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1515","01877"],"gpt_icon":0},{"id":"2593874254","title":"君实生物12月22日主力净流出367.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2593874254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593874254?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:16","pubTimestamp":1766391362,"startTime":"0","endTime":"0","summary":"12月22日, 君实生物股价跌0.60%,报收23.10元,成交金额4324.4万元,换手率0.71%,振幅3.18%,量比0.59。君实生物今日主力资金净流出367.4万元,上一交易日主力净流入284.6万元。该股近5个交易日下跌2.69%,主力资金累计净流出25.2万元;近20日主力资金累计净流入2302.6万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222162344a4698780&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222162344a4698780&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1583","BK1515","BK1161"],"gpt_icon":0},{"id":"2592197938","title":"每日卖空追踪 | 君实生物 12月19日卖空量成交25.24万股,卖空比例为8.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592197938","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592197938?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133024,"startTime":"0","endTime":"0","summary":"君实生物北京时间12月19日,涨3.38%,卖空量成交25.24万股,较上一交易日减少48.93%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163342a45f34c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163342a45f34c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1515","BK1583","BK1161"],"gpt_icon":0},{"id":"2592044139","title":"医药股集体走高 药明生物(02269)涨5.93% 机构料明年板块稳中向好态势延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2592044139","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592044139?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:23","pubTimestamp":1766111038,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股集体走高,药明生物 涨5.93%,药明合联涨4.56%,君实生物涨4.54%,康诺亚-B涨4.19%,荣昌生物涨3.98%,科伦博泰生物-B涨4.00%,泰格医药涨4.30%,复宏汉霖涨3.72%,诺诚健华涨3.26%。交银国际发布医药行业周报,展望2026年,该机构认为板块稳中向好态势延续,但影响市场表现的核心因素或呈分化态势,后续选股逻辑或将重回基本面和估值,即关注存在基本面预期差、当前仍被低估的个股。","market":"other","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971870","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU0196878994.USD","BK1576","LU0359201612.USD","02269","LU0417516902.SGD","LU0708995583.HKD","LU0327786744.USD","LU0819121731.USD","LU0823426480.USD","LU1242518931.SGD","159938","LU2328871848.SGD","LU2488822045.USD","02162","BK1587","LU0181495838.USD","LU0417516738.SGD","SG9999014674.SGD","01877","IE00B0JY6N72.USD","LU0823426308.USD","09939","HK0000165453.HKD","LU0051755006.USD","LU1688375341.USD","SG9999002562.SGD","LU1969619763.USD","LU0348735423.USD","LU0052750758.USD","02696","03347","06990","BK1161","LU0359202008.SGD","LU1880383366.USD","BK1610","LU0348825331.USD","09969","LU0856984785.SGD","02268","BK1141","09995","BK1521","BK1574","LU0516422366.SGD","LU1242518857.USD","LU0572944931.SGD","LU0588546209.SGD","LU0039217434.USD"],"gpt_icon":0},{"id":"2592087977","title":"君实生物:上海檀英拟减持不超2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2592087977","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592087977?lang=zh_cn&edition=full","pubTime":"2025-12-18 19:03","pubTimestamp":1766055835,"startTime":"0","endTime":"0","summary":"每经AI快讯,12月18日,君实生物(688180.SH)公告称,持股5%以上股东上海檀英因基金期限与流动性资金安排,计划通过大宗交易方式减持其持有的公司股份不超过2053.38万股,占公司总股本的2%。减持期间为2026年1月13日至2026年4月10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512183595608583.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512183595608583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","688180","BK0239","BK1161","BK1583","01877"],"gpt_icon":0},{"id":"2592917811","title":"每日卖空追踪 | 君实生物 12月17日卖空量成交2.06万股,卖空比例为0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592917811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592917811?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960224,"startTime":"0","endTime":"0","summary":"君实生物北京时间12月17日,跌0.43%,卖空量成交2.06万股,较上一交易日减少90.61%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163340a6ad24a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163340a6ad24a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","01877","BK1515"],"gpt_icon":0}],"profile":{"websiteUrl":"http://junshipharma.com","stockEarnings":[{"period":"1week","weight":-0.0124},{"period":"1month","weight":-0.0599},{"period":"3month","weight":-0.2985},{"period":"6month","weight":-0.0998},{"period":"1year","weight":0.9893},{"period":"ytd","weight":0.044}],"compareEarnings":[{"period":"1week","weight":0.0201},{"period":"1month","weight":0.0224},{"period":"3month","weight":-0.0296},{"period":"6month","weight":0.1013},{"period":"1year","weight":0.3422},{"period":"ytd","weight":0.0276}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海君实生物医药科技股份有限公司是一家主要从事创新驱动生物制药业务的中国公司。该公司主营业务为创新药物的发现、临床研究和开发。该公司的主要产品包括特立普珠单抗注射液、依替维单抗、阿达木单抗注射液等用于治疗恶性肿瘤、自身免疫系统疾病、慢性代谢疾病、神经系统疾病和感染性疾病的药物。该公司还从事重组人源化抗PCSK9单克隆抗体注射液等药物的临床研发。该公司主要为国内外市场提供产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.092909},{"month":2,"riseRate":0.857143,"avgChangeRate":0.07747},{"month":3,"riseRate":0.714286,"avgChangeRate":0.049127},{"month":4,"riseRate":0.857143,"avgChangeRate":0.101581},{"month":5,"riseRate":0.428571,"avgChangeRate":0.004505},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.018268},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.014588},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.040587},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.026161},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.004518},{"month":11,"riseRate":0.571429,"avgChangeRate":0.043753},{"month":12,"riseRate":0.571429,"avgChangeRate":0.085319}],"exchange":"SEHK","name":"君实生物","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君实生物,01877,君实生物股票,君实生物股票老虎,君实生物股票老虎国际,君实生物行情,君实生物股票行情,君实生物股价,君实生物股市,君实生物股票价格,君实生物股票交易,君实生物股票购买,君实生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}